Custom, Excise & Service Tax Tribunal
Sun Pharmaceuticals Industries Ltd vs Vadodara-Ii on 26 December, 2025
Customs, Excise & Service Tax Appellate Tribunal
West Zonal Bench at Ahmedabad
REGIONAL BENCH- COURT NO. 1
Excise Appeal No. 12185 of 2019-DB
( Arising out of OIO-VAD-EXCUS-002-COM-007-19-20 dated 26/06/2019 passed by the
Commissioner of CGST & Central Excise -Vadodara-II)
Sun Pharmaceuticals Industries Ltd ...... Appellant
lot No. 24/2, GIDC Industrial Estate,
P
Phase-iv, Panoli, Tal: Ankleshwar
Bharuch, Gujarat
VERSUS
ommissioner of CGST &
C
Central Excise-Vadodara-II ......Respondent
st Floor... Room No.101, 1 New Central Excise Building, Vadodara, Gujarat- 390023 PPEARANCE: A Shri Ashok B Naval, Chartered Accountantfor the Appellant Shri R K Agarwal, Superintendent (AR) for the Respondent ORAM: C HON'BLE MR. SOMESH ARORA, MEMBER (JUDICIAL) HON'BLE MR. SATENDRA VIKRAM SINGH, MEMBER (TECHNICAL) Final Order No.11445/2025 DATE OF HEARING: 28.08.2025 DATE OF DECISION:26.12.2025 SATENDRA VIKRAM SINGH M/s Sun Pharmaceuticals Industries Ltd, Bharuch (100% EOU) (Appellant) are manufacturing Bulk Drugs under Chapter 29 of the Central Excise Tariff Act, 1985. They were working under 100% EOU scheme till 28.02.2014. While auditing of their records, Central Excise officers noticed that during the period from April 2011toFebruary2014,theappellanthad cleared/sold multiple products inDomesticTariffArea(DTA)atconcessional rateofdutyintermsofNotificationNo.23/2003-CEdated31.03.2003,some of which were never exportedwhileinsomecases,productsclearedinDTA were more than 90% of the FOB value of export of the said product. 2|Page E/12185/2019 1.1 After examining their reply, department found that the appellant had improperlyavailedthebenefitofabovenotificationandtherefore,theywere issued a show causenoticeon10.03.2017proposingrecoveryofshortpaid central excise duty of Rs. 3,90,82,282/- on excess DTA clearances, under Section 11A(4) along with applicable interest and penalty under Section 11AC(1)(c)oftheCentralExciseAct,1944.Inadjudicationproceedings,the Commissioner, CGST and Central Excise, Vadodara-II vide impugned order dated 26.06.2019 confirmed the above Central Excise duty demand along withinterestandimposedapenaltyequalto50%ofthedutyamountunder the proposed Section. Aggrieved with this order, the appellant filed appeal before this Tribunal. 2. In their appeal, appellants have taken the following grounds: - (i) The main allegations of the department are: - a) SomeoftheproductssoldinDTAweremorethan90%oftheFOB value of export of that product. b) DTA clearance of dis-similar products at concessional duty rate. c) SomeoftheproductsweresoldonlyinDTAonaconcessionalduty rate and were never exported. (ii) The benefit of concessional rate ofduty,intermsofNotification 23/2003-CE dated 31.03.2003 is available even in respect of similar goods. The goods exported by theappellantandthegoodsclearedin DTA are similar. Further, deemed exports are also to be treated as physical export while calculating DTA sale entitlement. There is no relevanceifanyproductclearedinDTAismorethan90%ofFOBvalue of export of thatspecificproductifoverallDTAsaleentitlementisnot exceeded. The demand is hit by limitationandinterestandpenaltyis not recoverable from them. (iii) In terms of above notification, read with para 6.8 (a) of Foreign Trade Policy, 2009-14, EOU can clear goods in DTA upto 50% ofFOB 3|Page E/12185/2019 value of the goods exported or expected to be exported. Units which aremanufacturingandexportingmorethanoneproductcanclearany of these products into DTA, upto 90% of FOB value of export of the specific products. FOB value has to be taken by adding bothphysical as well as deemed export of the specific products. (iv) The goods cleared by them in DTA sales and those exported are similar. Learned Commissioner has erred in distinguishing the goods based on the tradenameoftheproductsratherthantheirapplication whichisonlybasisfordecidingsimilargoods.IntermsofLOPgranted to them by the Development Commissioner, they are permitted to manufacture a) Bulk Drugs- API and b) Bulk Drugs Intermediates. (v) "Similar goods" have been defined in the Custom Valuation (import of goods) Rules, 2007 and the same definition has been referred to in the Foreign Trade Policy. The department has failed to appreciate their submissions on this point and wrongly confirmedthe duty without giving any reasons as to why Bulk Drugs and their Intermediateshavingsimilartherapeuticuse,cannotbeconsideredas similar products. (vi) As per Rule2(f)oftheCustomsValuation(importofgoods)Rules, 2007, "Similar goods" are defined as under:- "(1) "Similar goods" means imported goods- (i)Whichalthoughnotalikeinallrespects,havelikecharacteristicsand like component materials which enable them to perform the same functions and to becommerciallyinterchangeablewiththegoodsbeing valued having regard to the quality, reputation and the existence of trade mark; (ii) produced in the country in which the goods being valued were produced; and producedbythesamepersonwhoproducedthegoodsbeingvalued,or where no such goods are available, goods produced by a different person, 4|Page E/12185/2019 but shall not include imported goods where engineering, development work, art work, design work, plan or sketch undertaken in India were completed directly or indirectly by the buyer on these imported goods free of charge or at a reduced cost for use in connection with the production and sale for export of these imported goods. " (vii) Vide circular No. 85/95-Cus dated 26.07.1995, CBEC had clarified and issued guidelines to check similarly of goods. However, this circularhassincebeenrescindedbyissueofcircularNo.07/2006-Cus dated 13.01.2006 which also elaborates on "Similar goods" as under:- "paragraph 6.8 (a) of the FTP provides that EOU/EHTP/STP may sell goods upto 50% of FOB value of exports in DTA on payment of concessional duty subject to fulfilment of positive NFE. It also provides that within the entitlement of DTA sale, the unit has to sell in DTA its products similar to the goods, which are exported or expected to be exported. There has been doubt as to what constitutes 'similar goods". Further, when theunitsarenotrequiredtotakeanypermissionforDTA sale under paragraph 6.39.9, it is felt necessary to providedefinitionof "similar goods" to bring clarity and uniformity. Therefore, it has been decided that the definition of 'similar goods" would be based on the definition of similar goods as provided in the Customs Valuation (Determination of Price of Imported Goods) Rules, 1988. The term "similar goods"means"goodswhichisalthoughnotalikeinallrespects, havelikecharacteristicsandlikecomponentmaterialswhichenablethem to perform the same functions and to be commercially interchangeable with the goods which have been exported or expected to be exported having regard tothequality,reputationandtheexistenceoftrademark and produced in the same unit by the same person who produced the export goods". The Board's Circular No. 85/95 dated 26-7-95 issued in this regard stands rescinded." (viii) The department has neither considered the value of deemed exports nor the guidelines provided under Appendix-14-I-H, with referencetoDTAsalesentitlementwithinthreeyearsoftheaccrualof entitlement. If deemed export value is added in the total FOB value, they had not made any excess clearance in DTA. Ithasbeenheldby Hon'ble Gujarat High Court in case of Shilpa Copper Wire Industries 2011 (269) E.L.T. 17 (Guj.) that deemed export are to be treated as 5|Page E/12185/2019 physicalexportwhilecalculatingDTAsalesentitlements.Similarruling was given by CESTAT Ahmedabad in the case of Shree Rohini EnterprisesVs.CommissionerofCentralExcise,Surat-Iat2017(346) E.L.T.461(Tri.-Ahmd.)whichwasalsoaffirmedbyHon'bleSupreme Court as reported 2017 (346) ELTA137(SC).Infollowingcasesalso, it is held that value of deemed exports are to be included for calculating DTA sales entitlement :- ● CCE, Visakhapatnam Vs Sri Saritha Synthetics &IndustriesPvt. Ltd. 2016 (335) E.LT. 688 (Tri. Bang) ● Commr. of C. EX. & Cus., Surat Versus Mudra MarkeinPvt.Ltd. 2015 (323) E.L.T. 154 (Tri. - Ahmd.) ● CommissionerofC.EX.&Cus.,SuratVersusAmitexSilkMillsP. Ltd. 2007 (216) E.L.T. 589 (Tri. - Ahmd.) ● Commr. of Central Excise Versus Shilpa Copper Wire Industries 2011 (269) Ε.Ε.Τ. 17 (Guj.) ● Amitex Silk Mills Pvt. Ltd. Versus Commissioner of Central Excise, Surat-I 2006 (194) ELT 344 (Tri.- Del.) ● Commissioner Versus Metflow Cast Pvt. Ltd. 2016 (331) E.LT. 355 (Guj.) ● Commissioner Versus Metflow Cast Pvt. Ltd. 2016 (331) E.LT. 355 (Guj.) ● Nandan Synthetics Pvt. Ltd. Versus Commissioner Of C. EX. & S.T., Daman 2015 (315) E.L.T. 454 (Tri. - Ahmd.) (ix) They are eligible for quarterly DTA sale entitlement. Learned Adjudicating authority has calculated DTA entitlement without considering carried forward entitlement of the last quarter. (x) The show cause notice was issued on 10.03.2017 alleging suppressionoffactsfordemandingdutyfortheperiodfromApril2011 6|Page E/12185/2019 to February 2014 which is beyond the normal period of two years alleging suppression of fact. Extended period of limitation is not invokableintheircaseastheyhavebeenregularlyfilingER-2returns, quarterly and annual performance report as well as filing intimation letters to the Development Commissioner before each DTAclearance. He relied on the decision of Hon'ble Gujart High Court in the case of Commissioner Vs. Meghmani Dyes & Intermediates Ltd.2013 (288) E.L.T.514(Guj.),wherein,ithasbeenheldthatwheninformationwas provided in prescribed format, then department cannot ask for more information and allege suppression. They also rely on the following decisions:- ● Commissioner of C EX, Pune- Vs. Emcure Pharmaceuticals Ltd 2014 (307) ELT. 180 (Tri Mumbai) ● Commissioner of C. EX., Noida Versus Accurate Chemical Industries 20 14 (310) E.L.T. 441 (All.) ● Accurate Chemicals Industries VS. Commr. of C. EX., Noida, 2014 (300) E.LT. 451 (Tri. Del.), ● Commissioner of Central Excise, Jalandhar Versus Royal Enterprises 2016 (337) E.L.T. 482 (S.C.) ● Commissioner ofCus.,C.EX.&S.T.,IndoreVersusZYGPharma Pvt. Ltd. 2017 (358) E.L.T. 101 (Μ.Ρ.) ● Collector of Central Excise Versus Chemphar Drugs & Liniments 1989 (40) E.L.T. 276 (S.C.) (xi)Penaltyisnotimposableontheminthiscaseastheyhavenot made any contravention of nature specified in Section 11AC of the Central Excise Act, 1994. They rely on the following decisions:- ● Hindustan Steel V/S State of Orissa reported 1978 ELT (J.159) ● AkbarBadruddinJivaniV/SCollectorofCustomes,Bombay"AIR 1990 (SC) 1579 7|Page E/12185/2019 ● Mnaglam cement ltd. V/S CCE, Jaipur - 2004 (163) ELT 177 (Tri-Del) ● Whiteline Chemicals VS Commissioner of C. EX, Surat- 2008 (229) E.LT. 95 (Tri. Ahmd.) ● RosavarSteelsLtd.VSCommissionerofC.EX.,Coimbatore2011 (268) E.L.T. 280 (Tri. - Chennai) ● Prem Fabricators Vs Commissioner of C. EX., Ahmedabad-II; 2010 (250) E.LT. 260 (Tri. - Ahmd.) ● Shree Gobinddeo Glass Works Ltd. Versus Commissioner of C. EX., Kolkata-11 2008 (223) E.LT. 476 (Tri. - Kolkata) ● Jeevan Diesels And Electricals Ltd. Versus Commr. of C. EX. Puducherry 2019 (365) E.L.T. 397 (Mad.) ● VVF Limited Versus Commissioner of Central excise, Belapur 2011 (267) E.L.T. 134 (Tri. - Mumbai) ● Commissioner of Central Excise, Kol. IV VersusKusumProducts Ltd. 2012 (283) E.L.T. 433 (Tri. - Kolkata) In view oftheabove,theyprayedtoallowtheirappealbysettingasidethe impugned order. 3. Duringhearing,learnedCounselexplainedtheentireschemeincluding DTA entitlement and the provisions of Notification 23/2003 to impress that they have not breached any oftheconditionsofForeignTradePolicyorthe related notifications issued by CBIC. A wrong case has been made against them for demanding differential duty which is not payable if FOB value of Deemed exports is added to FOB value of physical exports for determining DTAsalesentitlementandtheircarriedforwardDTAsalesentitlementisalso allowed. The goods cleared in DTA are similar to goods exported by them andtherefore,ifallthesefactorsareconsidered,nodifferentialdutydemand remains against them. He also mentions that extended period is not 8|Page E/12185/2019 invokable in this case as they have been filing regular returns with the department. He also submitted following case laws to support hiscaseand prayed to allow their appeal :- ● CommissionerofCentralExcise,BangaluruVs.GlobalGreenCompany Ltd - 2022 (381) ELT 639 (Kar.) ● B.R.SteelProductsPvtLtdVs.CommissionerofC.Ex.,NaviMumbai- 2021 (378) ELT 356 (Tri.-Mumbai) ● ABI Turnamatics Vs. Commissioner of GST & C. Ex., Chennai- 2019 (366) ELT 1048 (Tri.- Chennai) 4. Learned AR on the other hand reiterated the findings of the CommissionerandsubmittedthattheAdjudicatingAuthorityhasclearlyheld that the goods sold/cleared by the appellant inDTAarenotsimilartowhat has been exported by them and thus, he has rightly concluded that the appellanthasviolatedtheconditionsofFTPandtherelatedNotifications.To citefewexamplesofsimilargoods,hedrawsourattentiontopage90ofthe appeal memorandum where the appellant has claimed that the product "Carisoprodol" and "Tizanidine HCL" are shown as Muscle Relaxant. As per him, if both are compared, they are not commercially interchangeable and to support his say, he produces the following table:- What is Carisoprodol What is Tizanidine Carisoprodol is a muscle Tizanidine is a short-acting relaxer that blocks pain muscle relaxer. It works by sensationsbetweenthenerves blocking nerve impulses (pain and the brain. sensations)thataresenttoyour Carisoprodol is used together brain. with rest and physicaltherapy Tizanidine is used to treat to treat skeletal muscle spasticitybytemporarilyrelaxing conditions such as pain or muscle tone. injury. 9|Page E/12185/2019 Carisoprodol should only be Tizanidine may also be used for used for short periods (up to purposes not listed in this two or three weeks) because medication guide. there is no evidence of its effectiveness in long term use and most skeletal muscle injuries are generally of short duration. Carisoprodol is considered a controlled substance in the United States. Prescribed for Nocturnal Leg Cramps, Muscle Spasm. Carisoprodolmayalsobeused for purposes not listed in this comparison guide. 4.1 It is also his say that a bunch of similar goods having a particular therapeuticvaluecannotbeconsidered'similar'toanotherbunchofsimilar goods having a particular therapeutic value. For example, medicines which are antidepressants cannot be said to be similar to medicines which are anticancer. Hetherefore,pleadsthattheappellanthasnotproducedanydataordetails to establish how their products have been termed as "similar goods". 4.2 On other points raised by the Learned counsel, he states that the commissioner in his impugned order justified invocation ofextendedperiod and non-inclusion of FOB value of deemed exports in the FOB value of physical exports. He also justifies Annexure A1 giving details of goods cleared in DTA only and the same were never exported by the appellant which is a clear violation of FTP and concessional notifications. 5. We have heard the rival submissions. We findthatthemainissuesin this case are: 10|Page E/12185/2019 a)Whether FOB value of deemed exports is liable to be added to physical exports for determining DTA sales entitlement? b)Whether goods canbesold/clearedinDTAbymorethan90%oftheFOB value of export of a particular product? c) WhethergoodssoldbytheappellantinDTAaresimilartothoseexported by him or, are there any goods which were only cleared in DTA? d)Whetherextendedperiodisrightlyinvokedforinthecasedemandingduty for the larger period? 5.1 We find that the appellant has claimedandalsosupportedbyvarious caselawsthatFOBvalueofdeemedexportsshouldbeincludedinFOBvalue ofphysicalexportsfordeterminingtheDTAsalesentitlement.Wehavegone into various case laws and find that the contention of the appellant is correct. In the case of M/s Shree Rohini Enterprises Vs Commissioner of Central Excise, Surat-I, this tribunal vide order reported at 2017(346)E.L.T.(461 held that the value of deemed export is also to be taken into account for determining 50% of the FOB value which will be permitted to be sold to domesticmarket.Thisorderhasalsobeenaffirmed by Hon'ble Supreme Court as reported vide 2017(346)ELT A-136(SC). Similar finding was given by Hon'ble Supreme Court in the case of Virlon Textile Mills LimitedVsCommissionerofCentralExcise,Mumbaireportedat 2007(211) ELT 357(SC) and again in the case of Union of India Vs Arvind Cotspinreportedat2022(382)ELT735(SC).Inthelatercase,theissuewas whether Development Commissionercouldhaverevieweditsdecisiondated 26.11.1999, of allowing DTA sale by calculating entitlement upon considerationofbothphysicalExportsanddeemedexports,aftermorethan fouryearson05/05/2004,onthegroundthatAppendix42oftheHandBook of Procedure had been amended to include physical exports for DTA entitlement. Hon'ble Court in para 10 observed as under:- 11|Page E/12185/2019 10."Inviewoftheabovepositionoflawemanatingfrompara9.9(b)ofthe EXIM Policy as stood at the relevant time and the decision of this Court in Virlon Textile (Supra), the very basis of the Show Cause Notice in this matter to the respondent seeking to question the permission granted after abouttenyearswhenithadalreadybeenoperatedandexecuted,cannotbe countenanced. For this reason alone, this appeal was required to be dismissed." Therefore, this issue needs relook by the learned Adjudicating Authority and he may re-check with the office of the Development Commissioner regarding the practice adopted by them as per EXIM Policy asstoodatthe relevant time, before determining whether the appellant has exceededDTA salesbeyondtheirentitlementtodemanddifferentialdutyunderNotification No. 23/2003-CE dated 31.03.2003. 5.2 It is also the claim of the appellant that if DTA sales are within the overall limit of 50% of the FOB value, then there is no bar in clearing any specificproductbymorethan90%oftheFOBvalueexportofthatproduct. During arguments, learned Counsel was asked to produce authority for making this claim but he could not produce anysuchguidelines/Authority. The relevant provisions of Foreign Trade Policy pertaining to DTA sales entitlement on FOB (para 6.08 (a) & (k)) are as under:- "6.8 DTA Sale of Finished Products/Rejects/Waste/ Scrap/Remnants and By-products (a) Units,otherthangemsandjewelleryunits,maysellgoodsupto 50% of FOB value of exports, subject to fulfilment of positive NFE,on payment of concessional duties. Within entitlement of DTA sale, unit may sell in DTA, its products similar to goods which are exported or expected to be exported from units. However, units which are manufacturing and exporting more than one product can sell any of these products into DTA, upto 90% of FOB value of export of the specific products, subject to the condition that total DTAsaledoesnot exceed the overall entitlement of 50% of FOB value of exportsforthe unit, as stipulated above. No DTA sale at concessional duty shall be permissible in respect of motor cars, alcoholic liquors, books, tea 12|Page E/12185/2019 (except instanttea),pepper&pepperproducts,marbleandsuchother items as may be notified from time to time. (k) In case of new EOUs, advance DTA sale will be allowed not exceeding 50% of its estimated exports for the first year, except pharmaceutical units where this will be based onitsestimatedexports for the first two years." WefindthatthereisalimitonDTAsaleofanyspecificproductnotmore than90%oftheFOBvalueofexportofthatparticularproductsubjecttonot exceeding overall DTA sales entitlementof50%ofFOBvalueofexports.In fact,wastes,andbyproductsetcifintendedtobeclearedinDTA,arealsoto remain within the overall limit of 50% of the FOB value of exports. We therefore, are not convinced with the arguments of the appellant and accordingly, remitthismattertothelearnedAdjudicatingauthoritytoseeif this limithasbeenbreachedinrespectofDTAsalesofanyspecificproduct. Incase,thisconditionhasbeenbreachedinrespectofanyspecificproduct, the appellant shall be liable to pay excise duty as per the relevant provisions. 5.3 It is also theclaimoftheappellantthatthedepartmenthaswrongly alleged dis-similarity of the goods cleared in DTA sale vis-à-vis those exported by them. With the help of a list of products, they have drawn attention of this Bench to establish that the products cleared in DTA sales are similar tothoseexportedbythem.Theyhavereliedonthedefinitionof "similargoods"aspertheCustomsValuation(importofgoods)Rules,2007, clarifications issued by the CBIC and Judicial pronouncements by various Courts/Tribunals regarding extending the benefit of DTA sale on similar products. However, what is 'similar' and what is 'not similar' has to be seen in the light of composition & use of each product with the help of guidelines issued by CBIC andForeignTradepolicy.Compositionanduseof Pharmaceutical drugs is a highly technical subject and therefore, it will be 13|Page E/12185/2019 proper if the similarity or otherwise is adjudged by the learned Commissioner based on parameters of composition, use for specific ailments, tradeorproprietarynameetc.ForthispurposeAdjudicating authority can allow appellant to submit on the basis of established Pharmacopoeias like British Pharmacopoeia or Indian Pharmacopoeia or similarity based on product patent. 5.4 Theappellanthasassailedinvocationofextendedperiod,onthe ground that they were regularly filing ER-2 returns with the Department, quarterly and annual performance reports and also intimating DTA clearances to the Development Commissioner. We however, find from their ER-2returnsthatconsolidatedfigures/details ofgoodsclearedinDTAsalearementionedwhereasissuesinvolvedin thepresentcasehavearisenafterdeeperscrutinyofdocumentsofthe Appellantbytheofficers.Theissuessuchassimilarityoftheproducts, DTA sales entitlement with reference to exports and carried forward balance of entitlement at the close of thepreviousquarter,cannotbe knownfromthedetailsprovidedbytheappellantintheirER-2returns and/orinotherintimations.Thesewereknowntothedepartmentonly when appellant's recordswereauditedbytheofficerswhichotherwise would have remained unnoticed. In para 4.9 of his order, Learned Commissionerhasdiscussedthisissueindetailandjustifiedinvocation of extended period in this case. Keeping in view of the facts in this case, we agree with thefindingsofthelearnedAdjudicatingauthority on this issue and hold thatextendedperiodoflimitationhascorrectly been invoked. 14|Page E/12185/2019 6. With above observation, we remit the matter to the Adjudicating Authority for deciding various issues raised by the appellant afresh in the light of above observations and then, re-determine central excise duty liability on the appellant, if any. The appeal is allowed by way of remand. (Pronounced in the open court on26.12.2025) (SOMESH ARORA) MEMBER ( JUDICIAL ) (SATENDRA VIKRAM SINGH) MEMBER ( TECHNICAL ) Raksha